HAVCR2 and leukemia: Accordingly, the expression of Tim-3 has been studied in a variety of cancers as well as in patients with CLL, but the expression of Fyn and Bat3, as the main down-stream adaptor molecules of Tim-3, has not been investigated in this leukemia.